Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented final first-in-human data for ...

Vercel has released Next.js 16.2, featuring performance enhancements that make development startup 400% faster and rendering ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Replimune received rejections in ...

It’s not just you. It really is getting harder to outpace the other guys. Our recent research finds that since the middle of the 1990s, which marked the mainstream adoption of the internet and ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...

The model will combine Mayo Clinic's de-identified clinical data with Microsoft's AI technology to support clinical reasoning, earlier diagnoses and personalized treatment.

At University Health Kansas City, frontline nurses are working together to redesign IT systems. Their goal: reduce burnout, cut alert fatigue and return thousands of hours to patient care.